Literature DB >> 17336241

Gastric cancer: D2 dissection or low Maruyama Index-based surgery--a debate.

Harold O Douglass1, Scott A Hundahl, John S Macdonald, Vijay P Khatri.   

Abstract

This article provides perspectives on the surgical approaches required optimally to manage patients with respectable gastric adenocarcinoma. The status of techniques of surgical resection in the management of gastric cancer is reviewed. The premise of this approach is that extended gastrectomy with D2 lymph node dissection is good. Also addressed are prognostic and predictive factors in the surgical treatment of stomach cancer.

Entities:  

Mesh：

Year:  2007        PMID： 17336241     DOI： 10.1016/j.soc.2006.10.005

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  11 in total

Review 1.  Strategies for treating liver metastasis from gastric cancer.

Authors:  Yoshihiro Kakeji; Masaru Morita; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

2.  D2 plus radical resection combined with perioperative chemotherapy for advanced gastric cancer with pyloric obstruction.

Authors:  Yian Du; Xiangdong Cheng; Zhiyuan Xu; Litao Yang; Ling Huang; Bing Wang; Pengfei Yu; Ruizeng Dong
Journal:  Chin J Cancer Res       Date:  2013-08       Impact factor: 5.087

3.  Robot-assisted laparoscopic gastrectomy with D2 dissection for adenocarcinoma: initial experience with 17 patients.

Authors:  R Pugliese; D Maggioni; F Sansonna; G C Ferrari; S Di Lernia; C Magistro; I Pauna; A Forgione; A Costanzi; C Brambilla; F Pugliese
Journal:  J Robot Surg       Date:  2008-11-26

4.  SAGES TAVAC safety and effectiveness analysis: da Vinci ® Surgical System (Intuitive Surgical, Sunnyvale, CA).

Authors:  Shawn Tsuda; Dmitry Oleynikov; Jon Gould; Dan Azagury; Bryan Sandler; Matthew Hutter; Sharona Ross; Eric Haas; Fred Brody; Richard Satava
Journal:  Surg Endosc       Date:  2015-07-24       Impact factor: 4.584

5.  Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections.

Authors:  Nobuyuki Takemura; Akio Saiura; Rintaro Koga; Junichi Arita; Ryuji Yoshioka; Yoshihiro Ono; Naoki Hiki; Takeshi Sano; Junji Yamamoto; Norihiro Kokudo; Toshiharu Yamaguchi
Journal:  Langenbecks Arch Surg       Date:  2012-05-22       Impact factor: 3.445

6.  Intestinal-type histology is associated with better prognosis in patients undergoing liver resection for gastric/esophagogastric-junction liver metastasis.

Authors:  Daisuke Ito; Yoshikuni Kawaguchi; Hiroharu Yamashita; Junichi Arita; Nobuhisa Akamatsu; Junichi Kaneko; Yoshihiro Sakamoto; Norihiro Kokudo; Yasuyuki Seto; Kiyoshi Hasegawa
Journal:  Glob Health Med       Date:  2019-12-31

Review 7.  Subtotal gastrectomy for gastric cancer.

Authors:  Roberto Santoro; Giuseppe Maria Ettorre; Eugenio Santoro
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

8.  Subtotal gastrectomy with D2 dissection by minimally invasive surgery for distal adenocarcinoma of the stomach: results and 5-year survival.

Authors:  Raffaele Pugliese; Dario Maggioni; Fabio Sansonna; Andrea Costanzi; Giovanni Carlo Ferrari; Stefano Di Lernia; Carmelo Magistro; Paolo De Martini; Francesco Pugliese
Journal:  Surg Endosc       Date:  2010-04-23       Impact factor: 4.584

Review 9.  The role of surgery in the therapeutic approach of gastric cancer liver metastases.

Authors:  Aikaterini Mastoraki; Christina Benetou; Sotiria Mastoraki; Ioannis S Papanikolaou; Nikolaos Danias; Vassilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  Indian J Gastroenterol       Date:  2016-08-16

10.  Repeat hepatectomy for recurrent liver metastasis from gastric carcinoma.

Authors:  Nobuyuki Takemura; Akio Saiura; Rintaro Koga; Ryuji Yoshioka; Junji Yamamoto; Norihiro Kokudo
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.